FrancophonIA/ELRC3.0 huggingface dataset:
English: The 100 mg vial contains an overfill to allow the withdrawal of 100 mg when reconstituted if following the directions described below.
Croatian: Bočica od 100 mg sadrži suvišak kako bi se omogućilo izvlačenje 100 mg lijeka kada se rekonstituira prema uputama opisanima u nastavku.
English: Synagis 50 mg/0.5 ml solution for injection Synagis 100 mg/1 ml solution for injection
Croatian: Synagis 50 mg/0,5 ml otopina za injekciju Synagis 100 mg/1 ml otopina za injekciju
English: Palivizumab is administered intramuscularly, preferably in the anterolateral aspect of the thigh.
Croatian: Palivizumab se daje intramuskularno, po mogućnosti u anterolateralno područje bedra.
English: Palivizumab is administered once a month intramuscularly, preferably in the anterolateral aspect of the thigh.
Croatian: Palivizumab se daje intramuskularno jednom mjesečno, po mogućnosti u anterolateralno područje bedra.
English: Label of 1.0 ml vial
Croatian: Naljepnica na bočici od 1,0 ml
English: Synagis 50 mg/0.5 ml solution for injection Synagis 100 mg/1 ml solution for injection Active substance: palivizumab
Croatian: Synagis 50 mg/0,5 ml otopina za injekciju Synagis 100 mg/1 ml otopina za injekciju Djelatna tvar: palivizumab
English: 1 ml of Synagis solution contains 100 mg of palivizumab*.
Croatian: 1 ml Synagis otopine sadrži 100 mg palivizumaba*.
English: - The other ingredients are, - for the powder: histidine, glycine and mannitol.
Croatian: - Pomoćne tvari su: - za prašak: histidin, glicin i manitol. - za otapalo: voda za injekcije.
English: Slowly add 0.6 ml of water for injections along the inside wall of the vial to minimise foaming.
Croatian: Polako dodati 0,6 ml vode za injekcije uz unutarnju stijenku bočice kako bi se smanjilo stvaranje pjene.
English: No polymorphic or non-polymorphic sequence variations outside of the A antigenic site on the RSV F protein were shown to render RSV resistant to neutralisation by palivizumab.
Croatian: A na proteinu RSV F nisu izazivale rezistenciju RSV-a na neutralizaciju palivizumabom.
English: Synagis 100 mg vial label
Croatian: Synagis 100 mg vanjska kutija
English: Liquid formulation of palivizumab
Croatian: Liofilizirani oblik palivizumaba
English: Slowly add 1.0 ml of water for injections along the inside wall of the vial to minimise foaming.
Croatian: Polako dodati 1,0 ml vode za injekcije uz unutarnju stijenku bočice kako bi se smanjilo stvaranje pjene.
English: Synagis 50 mg vial label
Croatian: Synagis 50 mg vanjska kutija
English: Synagis 100 mg/1 ml solution for injection palivizumab
Croatian: Synagis 100 mg/1 ml otopina za injekciju palivizumab
English: - Each 0.5 ml vial contains 50 mg of palivizumab.
Croatian: - Jedna bočica od 0,5 ml sadrži 50 mg palivizumaba.
English: Respiratory, thoracic and mediastinal disorders
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja često apneja
English: Synagis may cause serious side effects including: severe allergic reactions, such reactions may be life-threatening or fatal (see “Your child should not be given Synagis” for a list of signs and symptoms).
Croatian: Synagis može izazvati ozbiljne nuspojave, uključujući: teškealergijskereakcije,takvereakcijemogubitiopasnepoživotilismrtonosne(zapopis znakova i simptoma pogledajte dio "Vaše dijete ne bi smjelo primiti Synagis"). neuobičajene modrice ili skupine malih crvenih točkica na koži.
English: Each 0.5 ml vial contains 50 mg of palivizumab.
Croatian: Jedna bočica od 0,5 ml sadrži 50 mg palivizumaba.
English: Swirl gently.
Croatian: Nježno kružno okretati.
English: Signs and symptoms of a severe allergic reaction include: severe rash, hives, or itching skin swelling of the lips, tongue, or face closing of the throat, difficulty swallowing difficult, rapid, or irregular breathing bluish colour of skin, lips, or under fingernails muscle weakness or floppiness a drop in blood pressure unresponsiveness
Croatian: Ako je alergično napalivizumabili nekidrugi sastojak ovog lijeka (naveden u dijelu 6.).Znakovi i simptomi teške alergijske reakcije mogu obuhvaćati: teški osip, koprivnjaču ili svrbež kože oticanje usana, jezika ili lica zatvoreno grlo, otežano gutanje otežano, ubrzano ili nepravilno disanje plavičastu boju kože, usana ili područja ispod noktiju slabost ili mlohavost mišića pad krvnog tlaka izostanak reakcijena podražaje
English: Medicinal products for the treatment of severe hypersensitivity reactions, including anaphylaxis and anaphylactic shock, should be available for immediate use following administration of palivizumab.
Croatian: Prilikom primjene palivizumaba na raspolaganju za trenutnu primjenu trebaju biti lijekovi za liječenje teških reakcija preosjetljivosti, uključujući anafilaksiju i anafilaktički šok.
English: Synagis 50 mg/0.5 ml solution for injection palivizumab
Croatian: Synagis 50 mg/0,5 ml otopina za injekciju palivizumab
English: Like all medicines, this medicinecan causeside effects, although not everybody gets them.
Croatian: Kao i svilijekovi, ovaj lijekmože uzrokovati nuspojaveiako se one neće javiti kod svakoga.
English: On this basis, the absolute risk reduction is 5.8% which means the number needed to treat is 17 to prevent one hospitalisation.
Croatian: Na temelju toga je smanjenje apsolutnog rizika bilo 5,8%, što znači da je broj bolesnika koje treba liječiti da bi se spriječila jedna hospitalizacija 17. Nije bilo učinka na težinu RSV bolesti u djece koja su hospitalizirana unatoč profilaktičkoj primjeni palivizumaba ako se ona izrazi brojem dana boravka u jedinici intenzivne skrbi na 100 djece, odnosno brojem dana na mehaničkoj ventilaciji na 100 djece.
English: Outer Carton of 0.5 ml vial
Croatian: Vanjska kutija za bočicu od 0,5 ml
English: Studies using liquid palivizumab
Croatian: Ispitivanja s tekućim palivizumabom
English: - Each 1 ml vial contains 100 mg of palivizumab.
Croatian: - Jedna bočica od 1 ml sadrži 100 mg palivizumaba.
English: Synagis 100 mg powder and solvent for solution for injection
Croatian: Synagis 100 mg prašak i otapalo za otopinu za injekciju
English: Studies using lyophilised palivizumab
Croatian: Ispitivanja s liofiliziranim palivizumabom
English: Synagis 100 mg powder and solvent for solution for injection Active substance: palivizumab
Croatian: Synagis 100 mg prašak i otapalo za otopinu za injekciju Djelatna tvar: palivizumab
English: Synagis 50 mg powder and solvent for solution for injection Active substance: palivizumab
Croatian: Synagis 50 mg prašak i otapalo za otopinu za injekciju Djelatna tvar: palivizumab
English: Each vial contains 50 mg palivizumab, providing 100 mg/ml of palivizumab when reconstituted as recommended.
Croatian: Jedna bočica sadrži 50 mg palivizumaba što daje 100 mg/ml palivizumaba kada se pripremi kako je preporučeno.
English: Synagis 50 mg powder and solvent for solution for injection
Croatian: Synagis 50 mg prašak i otapalo za otopinu za injekciju
English: Lyophilised formulation of palivizumab
Croatian: Tekući oblik palivizumaba
English: Each 1 ml vial contains 100 mg of palivizumab.
Croatian: Jedna bočica od 1 ml sadrži 100 mg palivizumaba.
English: Synagis 100 mg powder and solvent for solution for injection palivizumab
Croatian: Synagis 100 mg prašak i otapalo za otopinu za injekciju palivizumab
English: Synagis 50 mg powder and solvent for solution for injection palivizumab
Croatian: Synagis 50 mg prašak i otapalo za otopinu za injekciju palivizumab
English: Ninety-seven percent of all subjects receiving palivizumab completed the study and 95% received all five injections.
Croatian: Ispitanici su razvrstani po vrsti srčanih lezija (cijanotične naspram ostale) te je 150 dana praćena sigurnost i djelotvornost. 97% ispitanika koji su dobivali palivizumab je završilo ispitivanje, dok je 95% dobilo svih pet injekcija.
English: 100 mg per vial, providing 100 mg/ml of palivizumab when reconstituted as recommended.
Croatian: 100 mg po bočici, što daje 100 mg/ml palivizumaba kada se pripremi kako je preporučeno.
English: Each vial contains: 100 mg palivizumab, providing 100 mg/ml of palivizumab when reconstituted as recommended.
Croatian: Jedna bočica sadrži 100 mg palivizumaba što daje 100 mg/ml palivizumaba kada se pripremi kako je preporučeno.
English: 50 mg per vial, providing 100 mg/ml of palivizumab when reconstituted as recommended.
Croatian: 50 mg po bočici, što daje 100 mg/ml palivizumaba kada se pripremi kako je preporučeno.
English: However, you should inform your doctor of all medicines your child is currently taking before starting Synagis.
Croatian: Ipak, prije primjene lijeka Synagis obavijestite liječnika ako Vaše dijete uzima bilo koje druge lijekove.
English: AbbVie Spain, S.L.U Tel: +34 9 1 384 09 10
Croatian: AbbVie Biofarmacevtska družba d.o.o. Tel: + 386 (1) 32 08 060
English: Concentration of 100 mg/ml solution for injection.
Croatian: Koncentracija otopine za injekciju iznosi 100 mg/ml.
English: Synagis 50 mg powder for solution for injection palivizumab
Croatian: Synagis 50 mg prašak za otopinu za injekciju palivizumab i.m.
English: Each vial contains 100 mg palivizumab*, providing 100 mg/ml of palivizumab when reconstituted as recommended.
Croatian: Jedna bočica sadrži 100 mg palivizumaba*, što nakon rekonstitucije kako je preporučeno daje 100 mg/ml palivizumaba.
English: Synagis 100 mg powder for solution for injection palivizumab
Croatian: Synagis 100 mg prašak za otopinu za injekciju palivizumab i.m.
English: Skin and subcutaneous tissue disorders
Croatian: Poremećaji kože i potkožnog tkiva vrlo često manje često osip urtikarija
English: Label of 0.5 ml vial
Croatian: Naljepnica na bočici od 0,5 ml
English: Each vial contains 50 mg palivizumab*, providing 100 mg/ml of palivizumab when reconstituted as recommended.
Croatian: Jedna bočica sadrži 50 mg palivizumaba*, što nakon rekonstitucije kako je preporučeno daje 100 mg/ml palivizumaba.
English: Administrator's Instructions
Croatian: UPUTA O LIJEKU
English: Tel.: +48 22 372 78 00
Croatian: AbbVie Polska Sp. z o.o. Tel.: + 48 22 372 78 00
English: Histidine Glycine
Croatian: KG Knollstrasse
English: Synagis may cause serious side effects including: severe allergic reactions,such reactions may be life-threatening or fatal (see "Your child should not be given Synagis" for a list of signs and symptoms).
Croatian: Synagis može izazvati ozbiljne nuspojave, uključujući: teškealergijskereakcije,takvereakcijemogubitiopasnepoživotilismrtonosne (vidjeti dio
English: Strength Pharmaceutical Form
Croatian: Jačina Farmaceutska forma
English: Content Package size
Croatian: Sadržaj Veličina pakiranja karencija
English: Invented Name
Croatian: Ime proizvoda
English: EU Number
Croatian: EMEA Broj
English: Packaging
Croatian: Način upotrebe Pakiranja
English: * Tissue culture infectious dose 50%.
Croatian: * 50% infektivne doze kulture tkiva.
English: ** Antibody micro agglutination-lytic reaction.
Croatian: ** Mikro aglutinacijska-litička reakcija antitijela
English: --1 Lyophilisate and suspension for suspension for injection
Croatian: Liofilizat i suspenzija za , suspenziju za injekciju
English: Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae strain MSLB 1089
Croatian: Suspenzija (inaktivirana) Leptospira interrogans serogrupa Icterohaemorrhagiae serovar Icterohaemorrhagiae, soj MSLB 1089
English: Lyophilisate: vial (glass) Suspension: vial (glass)
Croatian: Staklena bočica Suspenzihja : staklena bočica
English: Suspension: vial (glass)
Croatian: Staklena bočica Suspenzija: staklena bočica
English: Median OS (months)
Croatian: NAVOĐENJE DJELATNE(IH) TVARI
English: • Your female partner must also use a suitable method of contraception.
Croatian: • Vaša partnerica također mora koristiti odgovarajuću metodu kontracepcije.
English: * Not controlled for multiplicity.
Croatian: * Nije kontrolirana za višestrukost.
English: June 2021
Croatian: lipnja 2021.
English: It is important that you take the total recommended dose each day.
Croatian: Važno je da svaki dan uzmete ukupnu preporučenu dozu.
English: (8.3-NR)
Croatian: (8,3-ND)
English: The clinical relevance of this effect is unknown.
Croatian: Klinička značajnost ovog učinka je nepoznata.
English: Therefore, the specific dose recommendations for each formulation should be followed.
Croatian: Stoga se treba pridržavati specifičnih preporuka za doziranje svake formulacije.
English: Your doctor may prescribe a different dose if:
Croatian: Liječnik će Vam možda propisati drugačiju dozu:
English: Component of a multipack, not to be sold separately.
Croatian: Dio višestrukog pakiranja, ne smije se prodavati odvojeno.
English: It is recommended that you record the date when the capsules are removed from refrigerator and the date after which they should be discarded.
Croatian: Preporuča se da zabilježite datum kada ste izvadili kapsule iz hladnjaka i datum nakon kojeg ih je potrebno baciti.
English: • You should not become pregnant while taking this medicine.
Croatian: • Ne smijete zatrudnjeti dok uzimate ovaj lijek.
English: Pneumonitis is a serious condition that can often require hospital treatment.
Croatian: Pneumonitis je ozbiljna bolest koja često zahtijeva bolničko liječenje.
English: Two highly effective and complementary forms of contraception are recommended.
Croatian: Preporučuje se korištenje dviju visokoučinkovitih i komplementarnih metoda kontracepcije.
English: • every month for the first year of treatment
Croatian: • svaki mjesec tijekom prvih godinu dana liječenja
English: (events/patients)
Croatian: (događaji/bolesnice)
English: After this period, throw away any capsules that have not been used.
Croatian: Nakon tog razdoblja, bacite svaku kapsulu koja nije iskorištena.
English: Your doctor will tell you if there are any changes in your blood test that might need treatment.
Croatian: Liječnik će Vam reći ako dođe do bilo kakvih promjena u nalazima krvnih pretraga koje bi mogle zahtijevati liječenje.
English: Number of patients at risk:
Croatian: Broj bolesnica pod rizikom:
English: These specific cancer cells can be identified by:
Croatian: Te specifične stanice raka mogu se utvrditi:
English: Do not take a double dose (two doses at the same time) to make up for a forgotten dose.
Croatian: Nemojte uzeti dvostruku dozu (dvije doze odjednom) kako biste nadoknadili zaboravljenu dozu.
English: However, the number of patients is too limited to make meaningful conclusions on the efficacy in this subgroup.
Croatian: Međutim, broj bolesnika premalen je da bi se mogli donijeti smisleni zaključci o djelotvornosti lijeka u toj podskupini.
English: You will have a blood test:
Croatian: Napravit ćete krvne pretrage:
English: Locally advanced
Croatian: Lokalno uznapredovala
English: • Do not chew, crush, dissolve or divide the tablets as this may affect how quickly the medicine gets into your body.
Croatian: • Nemojte žvakati, drobiti, rastapati niti lomiti tablete jer to može utjecati na to koliko će brzo lijek dospjeti u tijelo.
English: Tell your doctor straight away if you notice any of the following:
Croatian: Odmah obavijestite liječnika ako primijetite bilo što od sljedećeg:
English: • ovarian cancer that has come back (recurred).
Croatian: • raka jajnika koji se vratio (recidiv).
English: Gender (%) Female Male
Croatian: Spol (%) Ženski Muški
English: Your doctor may lower your dose or stop treatment, either for a short time or permanently.
Croatian: Liječnik će Vam možda smanjiti dozu ili prekinuti liječenje, bilo nakratko ili trajno.
English: • changes in taste of foods (dysgeusia)
Croatian: • promjene okusa hrane (disgeuzija)
English: If you become pregnant during this time, you must talk to your doctor straight away.
Croatian: Ako zatrudnite tijekom tog razdoblja, morate se odmah obratiti svom liječniku.
English: The clinical study report should be submitted by:
Croatian: Izvješće kliničkog ispitivanja treba predati do:
English: Throw away any Lynparza capsules that have been frozen.
Croatian: Bacite svaku Lynparza kapsulu koja je bila zamrznuta.
English: INNER CARTON - with no blue box
Croatian: UNUTARNJA KUTIJA - bez plavog okvira
English: • if you are allergic to olaparib or any of the other ingredients of this medicine (listed in section 6)
Croatian: • ako ste alergični na olaparib ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.)
English: Chemotherapy n=97
Croatian: Kemoterapija n=97
English: twice a day - a total of 4 tablets each day.
Croatian: dvaput na dan - ukupno 4 tablete svakoga dana.
English: • at regular intervals decided by your doctor after the first year of treatment.
Croatian: • u redovitim intervalima (koje odredi Vaš liječnik) nakon prve godine liječenja.
English: Based on stratified log-rank test.
Croatian: Na temelju stratificiranog log-rang testa
English: Other laboratory findings
Croatian: Ostali laboratorijski nalazi
English: Any capsules that have been frozen must be discarded.
Croatian: Svaka kapsula koja je bila zamrznuta mora se odbaciti.
English: The medicines listed here may not be the only ones that could affect Lynparza.
Croatian: Ovdje navedeni lijekovi možda nisu jedini koji mogu utjecati na lijek Lynparza.
English: Antiemetic prophylaxis is not required.
Croatian: Profilaksa antiemeticima nije potrebna.
English: • a vaccine or a medicine that suppresses the immune system, as you may need to be closely monitored
Croatian: • cjepivo ili lijek koji potiskuje imunosni sustav, jer će Vas možda trebati pažljivo nadzirati
English: HR= Hazard Ratio.
Croatian: HR (engl. hazard ratio) = omjer hazarda.
English: If you take more Lynparza than you should
Croatian: Ako uzmete više lijeka Lynparza nego što ste trebali
English: June 2020
Croatian: lipnja 2020.
English: ECOG performance status (%)
Croatian: ECOG funkcionalni status (%)
English: • diarrhoea - if it gets severe, tell your doctor straight away.
Croatian: • proljev - ako postane težak, odmah se obratite svom liječniku
English: Lynparza should not be used during pregnancy.
Croatian: Lynparza se ne smije primjenjivati tijekom trudnoće.
English: These changes were reversible within 4 weeks of cessation of dosing.
Croatian: Te su se promjene povukle unutar 4 tjedna nakon prestanka primjene.
English: Hard capsule 112 capsules
Croatian: Tvrda kapsula 112 kapsula
English: months 0 6 12 18 24 30 36 42 48 54 60 66 72 78 84 90 96 nolaparib nplacebo
Croatian: mjeseci 0 6 12 18 24 30 36 42 48 54 60 66 72 78 84 90 96 nolaparib nplacebo
English: If your blood count falls to a low level, you may need to have a blood transfusion (where you are given new blood or blood-based products from a donor).
Croatian: Ako broj krvnih stanica padne na nisku razinu, možda će Vam biti potrebna transfuzija krvi (tijekom koje ćete primiti novu krv ili krvni derivat dobiven od darivatelja krvi).
English: Post-hoc analysis.
Croatian: Rezultati post-hoc analize
English: BOTTLE/LABEL
Croatian: BOCA/NALJEPNICA
English: December
Croatian: prosinca
English: Rarely, these may be a sign of more serious problems with the bone marrow such as ‘myelodysplastic syndrome' (MDS) or ‘acute myeloid leukaemia' (AML).
Croatian: Rijetko, to može biti znak ozbiljnijih problema s koštanom srži, kao što su 'mijelodisplastični sindrom' (MDS) ili 'akutna mijeloična leukemija' (AML).
English: • Take one dose (8 capsules) of Lynparza by mouth with water, once in the morning and once in the evening.
Croatian: • Uzmite jednu dozu lijeka Lynparza (8 kapsula) kroz usta s vodom, jedanput ujutro i jedanput navečer.
English: Please tell your doctor if you are taking a hormonal contraceptive, as your doctor may recommend the addition of a non-hormonal contraceptive method.
Croatian: Recite svome liječniku ako uzimate hormonski kontraceptiv jer će Vam on možda preporučiti da koristite i dodatnu, nehormonsku metodu kontracepcije.
English: Exploratory analyses of TFST and TSST were also performed.
Croatian: Provedene su i eksploracijske analize TFST-a i TSST-a.
English: It can affect the way the medicine works.
Croatian: Može utjecati na način djelovanja lijeka.
English: OUTER CARTON MULTIPACK -including the blue box
Croatian: VANJSKA KUTIJA VIŠESTRUKOG PAKIRANJA - uključuje plavi okvir
English: For women with hormone dependent cancer, two non-hormonal contraceptive methods should be considered.
Croatian: Kod žena s hormonski ovisnim rakom treba razmotriti korištenje dviju nehormonskih metoda kontracepcije.
English: • if you are breast-feeding (see section 2 below for more information).
Croatian: • ako dojite (pogledajte dio 2. za više informacija)
English: Study 19 (D0810C00019)
Croatian: Ispitivanje 19 (D0810C00019)
English: • Take Lynparza once in the morning and once in the evening.
Croatian: • Uzmite lijek Lynparza jedanput ujutro i jedanput navečer.
English: Other medicines and Lynparza
Croatian: Drugi lijekovi i Lynparza
English: Levels appeared to return to normal after treatment discontinuation and did not appear to have any clinical consequences.
Croatian: Vrijednosti su se naizgled vratile u normalu nakon prekida liječenja, bez ikakvih vidljivih kliničkih posljedica.
English: Lynparza capsules can be stored for up to 3 months below 30°C.
Croatian: Lynparza kapsule mogu se čuvati do 3 mjeseca na temperaturi ispod 30°C.
English: Uncommon side effects that may show up in blood tests: • increase in the size of red blood cells (not associated with any symptoms).
Croatian: Manje česte nuspojave koje mogu biti vidljive u nalazima krvnih pretraga: • povećanje veličine crvenih krvnih stanica (nije praćeno nikakvim simptomima)
English: Since it cannot be excluded that olaparib may reduce exposure to substrates of CYP2C9 through enzyme induction, the efficacy of some hormonal contraceptives may be reduced if co-administered with olaparib.
Croatian: Budući da se ne može isključiti mogućnost da olaparib može smanjiti izloženost supstratima CYP2C9 putem indukcije enzima, učinkovitost nekih hormonskih kontraceptiva može biti smanjena ako se primjenjuju istodobno sa olaparibom.
English: Majority of the material was excreted as metabolites.
Croatian: Većina materijala izlučena je u obliku metabolita.
English: See section 4 for more information about these side effects, including the signs and symptoms you need to look out for (for example, fever or infection, bruising or bleeding).
Croatian: Pogledajte dio 4. za više informacija o tim nuspojavama, uključujući znakove i simptome na koje morate pripaziti (primjerice, vrućica ili infekcija, pojava modrica ili krvarenje).
English: • allergic reactions (e.g. hives, difficulty breathing or swallowing, dizziness which are signs and symptoms of hypersensitivity reactions).
Croatian: • alergijske reakcije (npr. koprivnjača, teškoće pri disanju ili gutanju i omaglica, koje su znakovi i simptomi reakcije preosjetljivosti)
English: These may be low counts for red or white blood cells or low platelet counts.
Croatian: To može biti nizak broj crvenih ili bijelih krvnih stanica ili nizak broj krvnih pločica.
English: The 100 mg tablet is available for dose reduction.
Croatian: Tableta od 100 mg dostupna je za smanjivanje doze.
English: In repeat-dose toxicity studies of up to 6 months duration in rats and dogs, daily oral doses of olaparib were well-tolerated.
Croatian: U istraživanjima toksičnosti ponovljenih doza na štakorima i psima u trajanju do 6 mjeseci, svakodnevne peroralne doze olapariba dobro su se podnosile.
English: Consistent results were observed in all predefined patient subgroups (see Figure 7).
Croatian: Dosljedni su rezultati opaženi u svim unaprijed definiranim podskupinama bolesnika (vidjeti Sliku 7).
English: In particular, caution should be exercised if olaparib is administered in combination with any statin.
Croatian: Osobito je važan oprez kada se olaparib primjenjuje u kombinaciji s bilo kojim statinom.
English: If you notice any side effects not listed in this leaflet, please contact your doctor straight away.
Croatian: Ako primijetite bilo koju nuspojavu koja nije navedena u ovoj uputi, odmah se obratite svom liječniku.
English: • if you have low blood cell counts on testing.
Croatian: • ako imate nizak broj krvnih stanica na pretragama.
English: It is not known whether Lynparza may affect the effectiveness of some hormonal contraceptives.
Croatian: Nije poznato može li Lynparza utjecati na učinkovitost nekih hormonskih kontraceptiva.